fluorescein-5-isothiocyanate has been researched along with nociceptin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, M; Dong, SL; Li, J; Li, Z; Peng, YL; Wang, R; Yan, X; Zhang, BH; Zhou, LX | 1 |
| Brookes, ZL; Brown, NJ; Calo, G; Guerrini, R; Hebbes, CP; Lambert, DG; Reilly, CS; Stedman, EN | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and nociceptin
| Article | Year |
|---|---|
Effect and mechanism of nociceptin/orphanin FQ reversing multi-drug resistance in K562/ADM cell.
Topics: Annexins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium; Comet Assay; DNA; DNA Fragmentation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fas Ligand Protein; fas Receptor; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; K562 Cells; Nociceptin; Opioid Peptides; Spectrometry, Fluorescence | 2008 |
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
Topics: Animals; Cardiovascular System; CHO Cells; Cricetinae; Cricetulus; Fluorescein-5-isothiocyanate; Inflammation; Leukocyte Rolling; Male; Microcirculation; Microvessels; Narcotic Antagonists; Nociceptin; Nociceptin Receptor; Opioid Peptides; Rats; Rats, Wistar; Receptors, Opioid; Recombinant Proteins | 2013 |